All examined Haemophilus influenzae biogroup aegyptius isolates of the clone associated with Brazilian purpuric fever (the BPF clone) produced type 2 immunoglobulin A1 (IgA1) proteases encoded by identical iga genes that were distinct from the iga genes of other Brazilian H. influenzae biogroup aegyptius isolates. A partial nucleotide sequence analysis revealed close similarities to the iga genes of H. influenzae serotype c and one noncapsular H. influenzae biotype III strain isolated from a case of conjunctivitis in Tunisia, suggesting an evolutionary relationship. Epitopes recognized by neutralizing antibodies differed for the IgA1 proteases of the BPF clone and of other H. influenzae strains, including Brazilian H. influenzae biogroup aegyptius isolates from patients with noninvasive conjunctivitis. The low probability of developing cross-reacting neutralizing antibodies to the IgA1 protease of the BPF clone may contribute to the pathogenic potential of this virulent phenotype in Brazil.
Brazilian purpuric fever (BPF) is a syndrome of purulent conjunctivitis followed 1 to 3 weeks later by a fatal purpura fulminans resembling meningococcal meningitis (1) . BPF was first recognized in 1984 in Promissao, Sao Paulo State, Brazil. All analyzed cases in Brazil were caused by a single clone of the so-called Haemophilus influenzae biogroup aegyptius designated the BPF clone (2, 3) . The use of multilocus enzyme electrophoresis indicated resemblance to isolates of H. influenzae serotype c, which diverged from the BPF clone at an estimated genetic distance of 0.50. Notably, the BPF clone was not closely related genetically to other isolates classified as H. influenzae biogroup aegyptius or to selected representatives of the major phylogenetic lineages of encapsulated H. influenzae (22) . The sudden emergence of an unusually virulent clone among noncapsular bacteria previously associated with only local mucosal infection suggests that additional virulence factors, or a certain combination of such factors, have been acquired by this particular clone. The BPF clone has several distinct genotypic and phenotypic features, including a 24-MDa plasmid, a 25-kDa pilin protein, a 38-kDa protein shed into the supernatant, and increased virulence in an infant rat model (4) . However, the pathogenic role played by these features is not yet clear. Recently, Brazilian BPF-causing strains that lack the 24-MDa plasmid, although they share other characteristics of the BPF clone, have been reported (29) . In addition, blood isolates of two BPF cases from different areas in Australia did not share the characteristics of the BPF clone and lacked the 24-MDa plasmid (19, 20, 30) .
One potentially important strategy used by this invader is the subversion of the host immune defense by specific cleavage of immunoglobulin A1 (IgA1). This notion is supported by the fact that the microbial port of entry, i.e., the human conjunctiva, is protected primarily by antibodies of this isotype. Moreover, approximately 90% of IgA antibodies in human serum are IgA1 antibodies (5, 12) . Specific evasion of IgA1 is accomplished by the release of an enzyme, IgA1 protease, that attacks the hinge region of the molecule and thereby generates intact Fab ␣ and Fc ␣ fragments. The IgA1 proteases of strains of the closely related species Haemophilus aegyptius (for nomenclature, see Materials and Methods) were originally shown to cleave the peptide bond between proline and serine at positions 231 and 232, respectively (type 1 activity) (14) . Nevertheless, preliminary studies indicated that the IgA1 proteases of BPF clone isolates may be different in that they cleave between proline and threonine at positions 235 and 236, respectively (type 2 activity), a difference also reflected in the restriction fragment length pattern of the corresponding iga gene (4). Antigenic heterogeneity is displayed by IgA1 proteases of H. aegyptius, as two different types were distinguished among nine strains by use of enzyme-neutralizing antisera raised in rabbits against selected H. influenzae IgA1 proteases (14) . Conceivably, this diversity serves to circumvent enzymeneutralizing antibodies induced in the host by previous encounters with members of the species, as evidenced for noncapsular H. influenzae colonizing healthy children (18) . However, the antigenic properties of the IgA1 proteases secreted by members of the BPF clone have not been addressed. The present study was undertaken to characterize the IgA1 proteases of the BPF clone by using DNA sequencing and antibody-mediated enzyme neutralization.
MATERIALS AND METHODS
Nomenclature. The name H. aegyptius is used in this paper for authentic strains, including the type strain, of that formally existing species. Isolates received as H. influenzae biogroup aegyptius are referred to by that name. Some authors have suggested the latter designation in place of H. aegyptius on the basis of the scientific evidence that H. influenzae and H. aegyptius show a high degree of DNA homology and that H. aegyptius, for that reason, should be deleted as a separate species. However, this is in conflict with the International Code of Nomenclature of Bacteria (15) , as the name H. aegyptius has formal priority (8) . If the two species are combined into one taxon, the correct name will become H. aegyptius unless action is taken to conserve the epithet influenzae over the epithet aegyptius.
Bacterial isolates. Twenty-nine strains of H. influenzae biogroup aegyptius, kindly provided by M. C. C. Brandileone, Instituto Adolfo Lutz, Sao Paulo, Brazil, were examined. Epidemiologic data for the strains are given in Table 1 . Identification and biotyping were performed according to the method described by Kilian (13) .
IgA1 protease preparations.
All strains were grown overnight in 10 ml of Levinthal broth at 37ЊC in a humid atmosphere of air plus 5% CO 2 . The spent culture medium was used as a crude IgA1 protease preparation after removal of bacterial cells by centrifugation. Supernatants containing IgA1 protease were stored at Ϫ20ЊC until used. The IgA1 protease activity titer was determined as the reciprocal of the highest dilution that caused complete cleavage of IgA1 substrate (1 mg/ml) when incubated overnight, with equal volumes of enzyme and substrate. Cleavage of IgA1 was detected by immunoelectrophoresis as described previously (21) . For inhibition typing experiments, all proteases were adjusted to an activity titer of 4. IgA1 proteases used for immunization of rabbits to raise enzyme-neutralizing antibodies were made by the method of Higerd et al. (11) .
IgA1 protease cleavage specificity. The IgA1 protease cleavage specificity was determined by reducing sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis. Fragment sizes were determined by electrophoresis in 4 to 20% gradient gels in a Mini Protean II Slab Cell (Bio-Rad, Richmond, Calif.) after overnight incubation of equal volumes of enzyme and substrate IgA1 (5.6 mg/ml) purified from a patient with multiple myelomas (26) . The standards for type 1 and type 2 cleavages were H. influenzae strains HK393 and HK224, respectively.
Enzyme-neutralizing antibodies and inhibition typing. Rabbits were immunized subcutaneously every 2 weeks with 0.5 ml of IgA1 protease preparation in 0.5 ml of Freund's incomplete adjuvant until a satisfactory titer of enzyme neutralization was reached. The immunoglobulin fraction of serum was isolated as described previously (10), excluding the final gel filtration step. Rabbit antibodies were raised against 18 different H. influenzae IgA1 proteases. Details about the corresponding strains are given in Tables 1 and 2 by numbers in parentheses.
For inhibition typing, 10 l of adjusted IgA1 protease was mixed with 10 l of the appropriate antiserum and incubated for 1 h at room temperature. Subsequently, 20 l of IgA1 substrate (1 mg/ml) was added, and the reaction mixture was incubated overnight at 37ЊC. Cleavage of IgA1 was detected by immunoelectrophoresis. For titrations, twofold dilutions of antisera were used, and the titer was determined as the highest dilution that abolished cleavage of substrate IgA1.
Restriction fragment length polymorphism (RFLP) of the iga gene region. Chromosomal DNAs from H. influenzae biogroup aegyptius isolates were prepared as described previously (24) . Restriction endonucleases AluI and TagI were used according to the instructions of the manufacturer (Boehringer GmbH, Mannheim, Germany). Restriction endonuclease-digested DNA was electrophoresed in 1% agarose gels and subsequently blotted onto cellulose nitrate membranes by the Southern blot technique (27) . Filters were hybridized with a 4.5-kb HinfI-PstI fragment of plasmid pSPiga368 (25) PCR amplification and DNA sequence analysis. Primers for amplification of part of the iga gene of H. influenzae biogroup aegyptius strain 287/86, commercially synthesized (DNA Technology, Aarhus, Denmark) and including a recognition site for the restriction endonuclease EcoRI, were 5Ј GGAATTCCGG ATGTGGATTATCAAATATTCCG 3Ј and 5Ј GGAATTCCGTCTAATCGAC CGCCTCTAAAGCC 3Ј. A loopful of bacteria was boiled for 5 min in 10 l of H 2 O covered by 100 l of oil overlay, after which 90 l of an ice-cold reaction mixture (10 mM Tris-HCl [pH 8.8], 1.5 mM MgCl 2 , 75 mM KCl, 25 pmol of each primer, 60 M each of the four deoxynucleotides, and 3 U of Amplitaq DNA polymerase [Perkin-Elmer, Norwalk, Conn.]) was added on top of the overlay. PCR was performed by heating of the samples at 94ЊC for 5 min followed by 30 cycles of denaturation at 94ЊC for 1 min, annealing at 55ЊC for 2 min, and extension at 72ЊC for 2 min. Finally, the PCR was completed by extension at 72ЊC for 7 min.
The product from each of two individual PCRs was cloned into plasmid pCR by using the TA cloning system (Invitrogen, San Diego, Calif.) according to the protocol of the manufacturer. Sequencing was performed by the dideoxy-chain a Numbers in parentheses refer to antibodies raised against the corresponding IgA1 protease (see Table 3 ).
b NC, noncapsulated. c X, unique undefined cleavage specificity. 
RESULTS AND DISCUSSION
All 27 Brazilian isolates produced IgA1 protease, were hemin and NAD dependent, and had the characteristics of H. influenzae biotype III/biogroup aegyptius. The IgA1 proteases secreted by all 15 members of the BPF clone as well as strains 116/87 and 969/90, which are indistinguishable from the BPF clone except for a lack of the 24-MDa plasmid, showed exclusively type 2 cleavage specificity. The corresponding iga gene RFLP patterns examined were identical (Table 3 ). This finding suggests that the iga genes of all Brazilian BPF-causing strains are located on the chromosome and not on the 24-MDa plasmid. In contrast, all except one IgA1 protease of the 10 Brazilian non-BPF clone isolates showed type 1 cleavage specificity. Notably, the corresponding iga gene RFLP patterns were heterogeneous and different from that of the BPF clone (Table  3) . These data confirm previous preliminary findings (4) that the BPF clone elaborates an IgA1 protease qualitatively distinct among the variety of IgA1 proteases produced by Brazilian H. influenzae biogroup aegyptius isolates.
In order to gain further insight into the genetic relationships between the IgA1 proteases of the BPF clone and those of other strains of H. influenzae, part of the iga gene of the BPF clone, corresponding to nucleotides 412 to 1794 in the previously published H. influenzae HK368 iga gene sequence (23), was sequenced (Fig. 1) . This region encodes approximately the N-terminal half of the secreted IgA1 protease. This provided the opportunity for comparison of the iga gene of the BPF clone with a number of H. influenzae iga genes, including those of two serotype c isolates whose corresponding regions were previously analyzed (17) . Alignment and construction of a tree of proportional similarity (Fig. 2) showed the iga gene of the BPF clone to cluster among H. influenzae type 2 IgA1 proteases, with an overall similarity closest to the iga gene of noncapsular isolate HK284 (87.8% DNA identity and 84.8% amino acid identity) and slightly less close to the iga gene of serotype c strain HK635 (83% DNA identity and 79.6% amino acid identity). Comparison with the iga gene of serotype b strain HK368 showed only 70.6% DNA identity. These findings corroborate and extend a previous conclusion, based on multilocus enzyme electrophoresis (22) , that the BPF clone is related to H. influenzae serotype c strains. While the multilocus enzyme electrophoresis study in no case revealed a close relationship of the BPF clone to selected H. influenzae strains, the present study showed a high level of similarity to the iga gene of our own noncapsular strain HK284 (not included in the multilocus enzyme electrophoresis study by Musser and Selander [22] ). Interestingly, this strain was isolated in Tunisia in the early 1970s from a case of conjunctivitis, and, like the BPF clone, it possessed the biochemical activities characteristic of H. influenzae biotype III (13) . Accordingly, the BPF clone may be evolutionarily related to strains causing conjunctivitis in North Africa.
The part of the iga gene chosen for analysis in the present (32) 3 (128) 4 (32) 5 (64) 
ND ND
a BPF, member of the BPF clone recovered from patients with BPF or uncomplicated conjunctivitis; conj., non-BPF clone H. influenzae biogroup aegyptius isolate from uncomplicated conjunctivitis; Austr., Australian H. influenzae biogroup aegyptius isolate from blood of patient with purpuric fever. b 1 to 18, number of antibody preparation; ϩ, (ϩ), and Ϫ, complete, partial, and no inhibition of IgA1 protease activity, respectively; ND, not determined. A slash separates two different inhibition patterns observed. c The number in parentheses indicates the titer of inhibition against the IgA1 protease used for immunization. d For each of the two restriction endonucleases used, the RFLP patterns observed were arbitrarily designated by letters. Strain 969/90 was not examined.
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on March 1, 2013 by PENN STATE UNIV http://iai.asm.org/ study has previously been shown to consist of at least two different regions (9, 17) . The 5Ј region shows characteristic differences in sequence and length associated with enzymes of the two cleavage specificities and, accordingly, encodes molecular structures essential for determination of the cleavage specificity, i.e., the so-called cleavage specificity determinant (CSD) (9) . The sequence of the 3Ј region does not reflect cleavage specificity but shows highly variable areas interspersed with more-constant ones. By construction of a dendrogram of proportional similarity for each of these areas (Fig. 2) , the iga gene of the BPF clone was shown to display close similarity in the 5Ј region harboring the CSD to the iga genes of the two H. influenzae serotype c strains (93.5% DNA identity and 92% amino acid identity). Markedly less similarity to the serotype c iga gene in the 3Ј variable region was found (68.2% DNA identity and 62% amino acid identity). In contrast, comparison with the noncapsular strain HK284 disclosed a uniform level of similarity for both parts of the iga gene (88.2% DNA identity and 86.7% amino acid identity in the 5Ј region; 87.1% DNA identity and 82% amino acid identity in the 3Ј region). These observations point to separate evolutionary trajectories for the two iga gene regions, possibly due to events of horizontal genetic transfer between strains, as previously observed for other H. influenzae iga genes (17, 25) . The high level of similarity in the CSD among type 2 enzymes may be due to some functional constraint hindering variation in this particular region. Local antibodies that neutralize the IgA1 protease activities of BPF-causing strains conceivably are important parts of the host defense against this organism. Therefore, epitopes recognized by such antibodies were examined in the present study by using polyclonal rabbit antibodies. The neutralizing response elicited in rabbits against bacterial IgA1 proteases apparently is reproducible and correlates well with the response observed in humans during infection (16) . Specific epitopes that account for the inhibition have not been defined but appear to be of the discontinuous conformational type. Accordingly, IgA1 proteases of different ''inhibition types'' display several variable regions differing in their primary structures (17, 25) . Antibody preparations raised against H. influenzae IgA1 proteases representing 16 different inhibition types previously distinguished (14, 16, 18) , as well as against IgA1 proteases from two members of the BPF clone, were tested for neutralization of the 29 H. influenzae biogroup aegyptius IgA1 proteases included. The antibodies were used undiluted, corresponding to the titers of homologous inhibition given in Table 3 . With the exception of occasional examples of partial inhibition by one reference antibody preparation, IgA1 proteases of the BPF clone with or without the 24-MDa plasmid were exclusively neutralized by homologous antibodies (Table 3) . In contrast, all IgA1 proteases from non-BPF clone strains of H. influenzae biogroup aegyptius, including the two Australian isolates from cases of BPF, were neutralized by several reference antibody preparations displaying various patterns of inhibition (Table 3 ). In no case did antibodies to IgA1 protease secreted by the BPF clone neutralize IgA1 proteases of non-BPF clone H. influenzae biogroup aegyptius strains (Table 3 ). In conclusion, the IgA1 proteases secreted by members of the BPF clone with or without the 24-MDa plasmid possess epitopes recognized by inhibitory antibodies that are distinct from those of IgA1 proteases of other H. influenzae biogroup aegyptius IgA1 proteases collected in the same geographic area.
The finding that IgA1 proteases from Brazilian BPF-causing strains of H. influenzae biogroup aegyptius were not neutralized by the employed array of antibodies to various H. influenzae IgA1 proteases prompted us to examine 18 selected H. influenzae IgA1 proteases prepared from one strain each of serotypes a, d, and e, four strains of serotype b, three strains of serotype c, and eight noncapsular strains (Table 2) in enzyme neutralization assays. Antibody preparations raised against IgA1 proteases of two BPF clone isolates, 287/86 and 320/86 (homologous inhibition titers, 512), inhibited the IgA1 proteases of the three serotype c strains at inhibition titers of 1 to 4. The majority of the remaining 15 IgA1 proteases were not inhibited by these antibodies, while a few were inhibited at a titer of 1. Taken together with the high level of iga gene identity observed between serotype c strains and the BPF clone, especially in the part of the iga gene harboring the CSD, this finding is consistent with previous evidence that the CSD constitutes part of epitopes on the H. influenzae IgA1 protease recognized by neutralizing antibodies (6) . In this context, however, it was somewhat surprising that we found no similarity in such epitopes to the IgA1 protease of strain HK284, which showed a high degree of iga gene similarity to the BPF clone as well.
Epitopes recognized by neutralizing antibodies on the IgA1 protease of Brazilian BPF-causing strains of H. influenzae biogroup aegyptius apparently display limited similarity to those of most H. influenzae IgA1 proteases examined in this study. This finding may imply a rare occurrence, in the Brazilian host population, of preexisting neutralizing antibodies to this particular IgA1 protease. In this regard, evidence has been presented that successful establishment of noncapsular H. influenzae in the pharynx of healthy children is restricted to clones expressing an IgA1 protease not affected by antibodies induced by previously colonizing clones (18) . Accordingly, the present data may suggest the intriguing possibility that this unique antigenic type of IgA1 protease facilitates evasion of the local and systemic immune barriers by Brazilian BPF-causing strains and thereby contributes to their highly virulent phenotype. However, since the two Australian strains associated with purpuric fever produced an antigenically different IgA1 protease, this particular antigenic version of the IgA1 protease is not essential for causing the purpuric fever.
